Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unacylated ghrelin infusion during euglycemic-hyperinsulinemic clamp in overweight adults with type 2 diabetes
NL-OMON28343Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of unacylated ghrelin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Erasmus MC. Primary endpoint: Insulin levels. Started Sep 2011; status: active, not recruiting.
02
Drugs
unacylated ghrelin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON28343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28343.